Archer progresses quantum computer measurement

Materials technology company Archer Materials has successfully built its first qubit control device (ESR devices) (main picture) which will be used to measure the quantum information residing on the CQ quantum computing chip the company is developing. The company also released a high-magnification image of part of the prototype nanoscale device (below), which was created…

XTEK raises $11.4 million and joins C4 EDGE consotrium

Defence technology group XTEK is raising $11.4 million from investors and also moving to join the C4 EDGE consortium of 17 SMEs that are developing a sovereign C4 (commend, control, communications and computing) environment for the Australian army. The company announced it had successfully raised $9.2 million from an oversubscribed placement with institutional investors, and…

Manufacturing should triple its contribution to Australian GDP: Liveris

The final report of the National COVID-19 Commission’s manufacturing taskforce is expected to recommend policy changes including around energy, procurement, and commercialising public R&D work. Brent Balinski spoke to the taskforce’s head, Andrew Liveris, about ways to maximise manufacturing’s contribution in the economic recovery and beyond.

Alexium introduces new fabric cooling technology

Chemistry technology company Alexium International has introduced a new fabric and foam products cooling system to complement its core range. The company’s new Alexicool Phonon product cools bedding, upholstery and apparel materials by counteracting the insulative effect of textiles, moving heat away from the consumer. Until now the company’s technology has worked by absorbing heat…

Bluglass installs commercial-scale semiconductor equipment at Silverwater plant

Semiconductor technology developer Bluglass has completed the installation of its largest-ever remote plasma vapour deposition (RPCVD) manufacturing system (main picture) at its Silverwater plant in Sydney. The commercial-scale system, known as BLG-500, is capable of creating 6×6 semiconductor wafers or 42 two inch wafers for the production of laser diodes, LED and microLED industries. It…

Recce Pharmaceuticals tests Covid treatment

Recce Pharmaceuticals will trial its anti-infective agents RECCE 327 and RECCE 529 against SARS- CoV-2. The company has teamed with North Carolina’s Path BioAnalytics to trial its broad-spectrum synthetic antibiotics which the company is commercialising to defeat resistant superbugs, Researchers at PBA will evaluate the company’s drug candidates in an ‘ex vivo respiratory organoid model…